We'll get the full data pack / presentation over the next week or 2. Then we'll really see what this drug can do. This is the headline I wanted to see - It works on staph. My only question is around the omission of MRSA specifically as they have always discussed staph and MRSA as two separate things to investigate. I hope this is just due to the fact it is "top line data" and perhaps needs to be broken out further. I also think this is why the market reaction isn't quite there yet.
I bought more on open @ 17.5. No problem
Ann: Phase 2a Study Shows BTX 1801 Eradicates S. Aureus, page-165
-
- There are more pages in this discussion • 836 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.5¢ |
Change
0.025(6.58%) |
Mkt cap ! $734.6M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 40.5¢ | 37.5¢ | $3.018M | 7.647M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 211394 | 39.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 853 | 2 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |